Biomarin Pharmaceutical Stock Target Price and Analyst Consensus
| BMRN Stock | USD 65.09 0.83 1.29% |
The current analyst and expert consensus on Biomarin Pharmaceutical is Strong Buy with 8 buy recommendations. The current projected Biomarin Pharmaceutical target price consensus is 116.95, with 27 analyst opinions. Biomarin Pharmaceutical buy-or-sell recommendation module provides average expert sentiment on the projected Biomarin Pharmaceutical target price to derive its highest and lowest estimates based on target price estimated volatility of 2.595. Check out Macroaxis Advice on Biomarin Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.
Lowest Forecast 106.42 | Highest Forecast 129.81 | Target Price 116.95 |
Biomarin |
It's important to approach Biomarin Pharmaceutical's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Biomarin Pharmaceutical price targets
Biomarin Pharmaceutical's stock target price is an estimate of its future price, usually made by analysts. Using Biomarin Pharmaceutical's target price to determine if it is a suitable investment can be done through the following steps:- Look at Biomarin Pharmaceutical's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Biomarin Pharmaceutical's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Biomarin Pharmaceutical Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Biomarin Pharmaceutical is a key component of Biomarin Pharmaceutical valuation and have some predictive power on the future returns of a Biomarin Pharmaceutical.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Momentum Invested over 40 shares | |
 | Disruptive Technologies Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Manufacturing Invested over 30 shares | |
 | ESG Investing Invested few shares |
Check out Macroaxis Advice on Biomarin Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.